A Rare Association Between Leukocyte Adhesion Deficiency Type I and Psoriasis in Humans.
10.4168/aair.2011.3.2.138
- Author:
Zeinab A EL-SAYED
1
;
Dalia H EL-GHONEIMY
;
Heba ABD-ALLAH
;
Hanaa M AFIFI
Author Information
1. Department of Pediatrics, Ain Shams University, Cairo, Egypt. zeinabawad@gmail.com
- Publication Type:Case Report
- Keywords:
beta2 integrins;
LAD-I;
psoriasis
- MeSH:
Animals;
Antigens, CD18;
Child;
Dermatitis;
Gingivitis;
Glycoproteins;
Humans;
Leukocytes;
Leukocytosis;
Mice;
Neutrophils;
Periodontitis;
Psoriasis;
Skin;
Suppuration;
T-Lymphocytes
- From:Allergy, Asthma & Immunology Research
2011;3(2):138-140
- CountryRepublic of Korea
- Language:English
-
Abstract:
The beta2 integrins are expressed exclusively on leukocytes and participate in many immune and inflammatory processes. This subfamily comprises four heterodimeric glycoproteins with a common beta-subunit, designated beta2 (CD18). Spontaneous mutations of the CD18 gene result in leukocyte adhesion deficiency type I (LAD-I). Low level of CD18 expression has also been implicated in the pathogenesis of psoriasis. We here describe a child with recurrent skin infections without pus formation, persistent gingivitis and periodontitis. His blood counts showed persistent leukocytosis (neutrophilia). CD11b expression was defective on neutrophils, while that of CD18 was normal. So, our patient represents a mild variant of LAD-I with possible dysfunctional CD18. Moreover, he developed psoriasis with reduced CD18 expression on CD4+ T-cells. Psoriasiform dermatitis has been described before in association with LAD-I, however, clinically and histologically confirmed psoriasis in association with LAD-I has been described only in CD18 hypomorphic mice. Therefore, our patient represents the first clinically and histopathologically documented association between LAD-I and psoriasis in humans. It lends support to the role of beta2 integrins in the etiopathogenesis of psoriasis.
